Bumetanide

Product NDC: 70518-3191
11-digit product format: 705183191
Labeler code: 70518
Product ID: 70518-3191_c9490953-6ad0-9c33-e053-2995a90a6541
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Bumetanide
Dosage form: TABLET
Route: ORAL
Labeler: REMEDYREPACK INC.
Application: NDA018225
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2021-08-10
Marketing end: 0000-00-00
Substance: BUMETANIDE
Active strength: 2 mg/1
Pharmacologic classes: Loop Diuretic [EPC],Increased Diuresis at Loop of Henle [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70518-3191-0	2023-03-21	C162847	48780-1	f386c649-b0bb-0266-e053-dadaa90a7c1a	094283ec-efb7-4d5b-9822-84a6cdb59436
70518-3191-0	2023-01-30	C162847	48780-1	f386c649-b0bb-0266-e053-dadaa90a7c1a	094283ec-efb7-4d5b-9822-84a6cdb59436

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0Y2S3XUQ5H	BUMETANIDE	28395-03-1	BUMETANIDE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-3191-0	70518319100	30 TABLET in 1 BLISTER PACK (70518-3191-0)	30 tablet	2021-08-10	0000-00-00	No	No	Current